Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Gallego

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Substance Use & Misuse|May 1, 1997
Drugs, crime, and HIVC G Leukefeld, M A Gallego, D Farabee
Cutis|July 1, 1996
Areolar sebaceous hyperplasia: a case reportI Belinchón, A Aguilar, J Tardío, et al.
Clinical and Experimental Dermatology|July 1, 1995
Partial unilateral lentiginosis: report of seven cases and review of the literatureE Piqué, A Aguilar, M C Fariña, et al.
Acta Otorrinolaringologica Espanola|December 19, 2002
[Antitumoral effect of HSV-tk suicide gene associated with ganciclovir in an experimental model of head and neck epidermoid carcinoma]M S Boleas Aguirre, S Fernández González, M A Gallego Madrid, et al.
Cutis|February 1, 1996
Kaposi's sarcoma with an intense parasitization by LeishmaniaM A Gallego, A Aguilar, S Plaza, et al.
Journal of Healthcare Quality Research|January 26, 2021
[Failure mode effect analysis for safety improvement in the automatic drug dispensing systems]E Prado-Mel, M Mejías Trueba, I Reyes González, et al.
Oncogene|October 2, 2007
Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathwayM-A Gallego, C Ballot, J Kluza, et al.
Contact Dermatitis|August 14, 2024
Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)P Chicharro, M Munera-Campos, V Zaragoza-Ninet, et al.
Actas Dermo-Sifiliograficas|October 11, 2025
[Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.
Actas Dermo-Sifiliograficas|March 2, 2025
Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Substance Use & Misuse|May 1, 1997
Drugs, crime, and HIVC G Leukefeld, M A Gallego, D Farabee
Cutis|July 1, 1996
Areolar sebaceous hyperplasia: a case reportI Belinchón, A Aguilar, J Tardío, et al.
Clinical and Experimental Dermatology|July 1, 1995
Partial unilateral lentiginosis: report of seven cases and review of the literatureE Piqué, A Aguilar, M C Fariña, et al.
Acta Otorrinolaringologica Espanola|December 19, 2002
[Antitumoral effect of HSV-tk suicide gene associated with ganciclovir in an experimental model of head and neck epidermoid carcinoma]M S Boleas Aguirre, S Fernández González, M A Gallego Madrid, et al.
Cutis|February 1, 1996
Kaposi's sarcoma with an intense parasitization by LeishmaniaM A Gallego, A Aguilar, S Plaza, et al.
Journal of Healthcare Quality Research|January 26, 2021
[Failure mode effect analysis for safety improvement in the automatic drug dispensing systems]E Prado-Mel, M Mejías Trueba, I Reyes González, et al.
Oncogene|October 2, 2007
Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathwayM-A Gallego, C Ballot, J Kluza, et al.
Contact Dermatitis|August 14, 2024
Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)P Chicharro, M Munera-Campos, V Zaragoza-Ninet, et al.
Actas Dermo-Sifiliograficas|October 11, 2025
[Translated article] Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) Still be Part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.
Actas Dermo-Sifiliograficas|March 2, 2025
Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?C P Hernández Fernández, L Borrego, A M Giménez Arnau, et al.
Pageof 1